Bio En Pink Sheet Forward View - Simple Regression

BENH Stock  USD 0  0.00  0.00%   
Bio Pink Sheet outlook is based on your current time horizon. We recommend always using this module together with an analysis of Bio En's historical fundamentals, such as revenue growth or operating cash flow patterns.
As of 31st of January 2026 the relative strength index (rsi) of Bio En's share price is below 20 suggesting that the pink sheet is significantly oversold. The fundamental principle of the Relative Strength Index (RSI) is to quantify the velocity at which market participants are driving the price of a financial instrument upwards or downwards.

Momentum 0

 Sell Peaked

 
Oversold
 
Overbought
The successful prediction of Bio En's future price could yield a significant profit. We analyze noise-free headlines and recent hype associated with Bio En Holdings Corp, which may create opportunities for some arbitrage if properly timed.
Using Bio En hype-based prediction, you can estimate the value of Bio En Holdings Corp from the perspective of Bio En response to recently generated media hype and the effects of current headlines on its competitors.
The Simple Regression forecasted value of Bio En Holdings Corp on the next trading day is expected to be 0 with a mean absolute deviation of 0 and the sum of the absolute errors of 0.

Bio En after-hype prediction price

    
  USD 0.0022  
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as pink sheet price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
  
Check out Historical Fundamental Analysis of Bio En to cross-verify your projections.

Bio En Additional Predictive Modules

Most predictive techniques to examine Bio price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Bio using various technical indicators. When you analyze Bio charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
Simple Regression model is a single variable regression model that attempts to put a straight line through Bio En price points. This line is defined by its gradient or slope, and the point at which it intercepts the x-axis. Mathematically, assuming the independent variable is X and the dependent variable is Y, then this line can be represented as: Y = intercept + slope * X.

Bio En Simple Regression Price Forecast For the 1st of February

Given 90 days horizon, the Simple Regression forecasted value of Bio En Holdings Corp on the next trading day is expected to be 0 with a mean absolute deviation of 0, mean absolute percentage error of 0, and the sum of the absolute errors of 0.
Please note that although there have been many attempts to predict Bio Pink Sheet prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Bio En's next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).

Bio En Pink Sheet Forecast Pattern

Backtest Bio En  Bio En Price Prediction  Buy or Sell Advice  

Bio En Forecasted Value

In the context of forecasting Bio En's Pink Sheet value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. Bio En's downside and upside margins for the forecasting period are 0 and 0, respectively. We have considered Bio En's daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Market Value
0
0
Expected Value

Model Predictive Factors

The below table displays some essential indicators generated by the model showing the Simple Regression forecasting method's relative quality and the estimations of the prediction error of Bio En pink sheet data series using in forecasting. Note that when a statistical model is used to represent Bio En pink sheet, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.
AICAkaike Information Criteria37.8557
BiasArithmetic mean of the errors None
MADMean absolute deviation0.0
MAPEMean absolute percentage error0.0
SAESum of the absolute errors0.0
In general, regression methods applied to historical equity returns or prices series is an area of active research. In recent decades, new methods have been developed for robust regression of price series such as Bio En Holdings Corp historical returns. These new methods are regression involving correlated responses such as growth curves and different regression methods accommodating various types of missing data.

Predictive Modules for Bio En

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Bio En Holdings. Regardless of method or technology, however, to accurately forecast the pink sheet market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the pink sheet market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Hype
Prediction
LowEstimatedHigh
0.0000.00
Details
Intrinsic
Valuation
LowRealHigh
0.0000.00
Details

Bio En After-Hype Price Density Analysis

As far as predicting the price of Bio En at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Bio En or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Pink Sheet prices, such as prices of Bio En, with the unreliable approximations that try to describe financial returns.
   Next price density   
       Expected price to next headline  

Bio En Estimiated After-Hype Price Volatility

In the context of predicting Bio En's pink sheet value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Bio En's historical news coverage. Bio En's after-hype downside and upside margins for the prediction period are 0.00 and 0.00, respectively. We have considered Bio En's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
0
0
After-hype Price
0.00
Upside
Bio En is very steady at this time. Analysis and calculation of next after-hype price of Bio En Holdings is based on 3 months time horizon.

Bio En Pink Sheet Price Outlook Analysis

Have you ever been surprised when a price of a Company such as Bio En is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Bio En backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Pink Sheet price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Bio En, there might be something going there, and it might present an excellent short sale opportunity.
Expected ReturnPeriod VolatilityHype ElasticityRelated ElasticityNews DensityRelated DensityExpected Hype
 0.00  
0.00
 0.00  
 0.00  
0 Events / Month
1 Events / Month
In 5 to 10 days
Latest traded priceExpected after-news pricePotential return on next major newsAverage after-hype volatility
0
0
0.00 
0.00  
Notes

Bio En Hype Timeline

Bio En Holdings is currently traded for 0. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. Bio is estimated not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is estimated to be very small, whereas the daily expected return is currently at 0.0%. %. The volatility of related hype on Bio En is about 0.0%, with the expected price after the next announcement by competition of 0.00. About 60.0% of the company shares are held by company insiders. The company has Price/Earnings (P/E) ratio of 292.86. Bio En Holdings recorded a loss per share of 0.0. The entity had not issued any dividends in recent years. The firm had 6:1 split on the 13th of August 2014. Given the investment horizon of 90 days the next estimated press release will be in 5 to 10 days.
Check out Historical Fundamental Analysis of Bio En to cross-verify your projections.

Bio En Related Hype Analysis

Having access to credible news sources related to Bio En's direct competition is more important than ever and may enhance your ability to predict Bio En's future price movements. Getting to know how Bio En's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Bio En may potentially react to the hype associated with one of its peers.

Other Forecasting Options for Bio En

For every potential investor in Bio, whether a beginner or expert, Bio En's price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Bio Pink Sheet price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Bio. Basic forecasting techniques help filter out the noise by identifying Bio En's price trends.

Bio En Related Equities

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Bio En pink sheet to make a market-neutral strategy. Peer analysis of Bio En could also be used in its relative valuation, which is a method of valuing Bio En by comparing valuation metrics with similar companies.
 Risk & Return  Correlation

Bio En Market Strength Events

Market strength indicators help investors to evaluate how Bio En pink sheet reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Bio En shares will generate the highest return on investment. By undertsting and applying Bio En pink sheet market strength indicators, traders can identify Bio En Holdings Corp entry and exit signals to maximize returns.

Story Coverage note for Bio En

The number of cover stories for Bio En depends on current market conditions and Bio En's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Bio En is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Bio En's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.

Other Macroaxis Stories

Our audience includes start-ups and big corporations as well as marketing, public relation firms, and advertising agencies, including technology and finance journalists. Our platform and its news and story outlet are popular among finance students, amateur traders, self-guided investors, entrepreneurs, retirees and baby boomers, academic researchers, financial advisers, as well as professional money managers - a very diverse and influential demographic landscape united by one goal - build optimal investment portfolios

Bio En Short Properties

Bio En's future price predictability will typically decrease when Bio En's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Bio En Holdings Corp often depends not only on the future outlook of the potential Bio En's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Bio En's indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding77.4 M
Cash And Short Term Investments15.6 K

Other Information on Investing in Bio Pink Sheet

Bio En financial ratios help investors to determine whether Bio Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Bio with respect to the benefits of owning Bio En security.